Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform
about
Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertensionArachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevanceStructure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding siteDeterminants of Cytochrome P450 2C8 Substrate Binding: STRUCTURES OF COMPLEXES WITH MONTELUKAST, TROGLITAZONE, FELODIPINE, AND 9-CIS-RETINOIC ACIDP450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissuesGene structure of CYP2C8 and extrahepatic distribution of the human CYP2CsCYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acidsCYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET)Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in miceEndothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heartSex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endotheliumEpoxides and soluble epoxide hydrolase in cardiovascular physiologyRole of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injuryThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Summary of information on human CYP enzymes: human P450 metabolism data.The transcriptional regulation of the human CYP2C genesThe anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.Characterization of the Tissue Distribution of the Mouse Cyp2c Subfamily by Quantitative PCR Analysis.The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading.Cytochrome P450 2C24: Expression, Tissue Distribution, High-Throughput Assay, and Pharmacological Inhibition.Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor.Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice.Stereoselective epoxidation of the last double bond of polyunsaturated fatty acids by human cytochromes P450.Drug-metabolizing cytochrome P450s in the brain.Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.Vascular pharmacology of epoxyeicosatrienoic acidsEpoxyeicosatrienoic acids and endothelium-dependent responses.Cytochrome P450-type hydroxylation and epoxidation in a tyrosine-liganded hemoprotein, catalase-related allene oxide synthase.Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis.CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients.Vitamin C activation of the biosynthesis of epoxyeicosatrienoic acids.Epoxyeicosatrienoic acid analogs and vascular function.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.
P2860
Q27000348-A74794C8-5EE8-4D52-9596-9D6C6CABC686Q27024958-6671A4C1-59D6-4755-9E82-872F3BFA700BQ27642793-39115A95-F0E4-4867-8C3E-7EBED8695C17Q27650327-0D6C2533-D7D5-4CBB-9528-02D9CD5BD63EQ28138121-4C292274-8771-449A-92F0-2396154DC7C2Q28144397-8565938B-4ABC-407C-BF09-19654EFE0A91Q28189908-560F574C-21ED-4E5D-AD1D-1B4189E9F6E2Q28307304-4CAE3A81-5E85-40C3-82DB-17DD1CC1ECABQ28385835-1A4248EC-2011-4ED7-B434-064911ECE575Q28392135-02002BD3-E342-4A77-9C7A-1CB8134F4B44Q28392398-B3D85007-B5E4-41DF-8077-D38D65DD1751Q28396313-B788C774-B113-49B8-8D93-B689C17913DAQ28397180-352D5529-4E87-4ADF-B0AC-466FEE74692AQ30486745-04F1B511-DD5F-4A2C-96F3-455379489439Q32103802-66C8DCC0-04C8-46E8-962B-B292FDFCBD67Q33597311-434CAB0E-1E34-41E4-B628-8C611F3E70DFQ33800226-DB59D24C-A55E-4407-9B1D-C37C1311E8A5Q33820136-19AA313F-79F4-4528-9A94-7A95E675CCA6Q33853700-140A313C-9594-43B3-AEE9-B3FD3A5BCF09Q33939653-A587455D-2F20-4CFB-9915-5845294AC59EQ34325249-8BF41E86-CF68-4EF0-906D-F9144D166613Q34356117-673D4C2B-91BD-4974-A74F-9988E8FFD2E3Q34378817-0A61A207-E965-46C2-850F-A8DF2654E342Q35016255-93733DF1-4B11-4E32-BE6A-FAD94CA965A2Q35030396-30903A35-2600-41CE-A529-014F6D2598C7Q35056911-9E222E77-7D03-4A74-B630-B35DE56FB85DQ35827269-199BA856-A29D-42B5-962E-A7848B28B4B7Q35903066-10039C78-1BF5-4988-8303-1C609EF1E2C2Q36027183-5DB4EE3C-716B-47F2-B333-29DC5236A739Q36027656-942443A3-D3CB-4EE9-A820-71863BC4E21EQ36097906-DEFC0D46-6011-497A-91C3-A0073D380F76Q36756985-22BB5509-A907-4774-A320-F72F3DCC22A7Q36861457-E0A0FA52-8D1E-4D16-A48E-B320450B958DQ36943169-C4C8E43C-5F56-44A1-84AB-13052ADC00BEQ37206338-7DCC8BDA-8B2A-46D0-BE3B-4FFA70B05EFBQ37457715-5CF125F7-312B-4A51-B660-9578DE60559AQ37645559-B4FA5176-2857-4E9B-B85C-721D71DB04CFQ37693177-143C4230-C3D9-459B-826F-A593D5F3305CQ37995534-0DE012C0-38D7-4E29-A3A5-5F26A5AC3278Q38130410-EFAC972A-871D-49D0-A781-EF15BB09C460
P2860
Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Molecular cloning, expression ...... donic acid epoxygenase isoform
@ast
Molecular cloning, expression ...... donic acid epoxygenase isoform
@en
Molecular cloning, expression ...... donic acid epoxygenase isoform
@nl
type
label
Molecular cloning, expression ...... donic acid epoxygenase isoform
@ast
Molecular cloning, expression ...... donic acid epoxygenase isoform
@en
Molecular cloning, expression ...... donic acid epoxygenase isoform
@nl
prefLabel
Molecular cloning, expression ...... donic acid epoxygenase isoform
@ast
Molecular cloning, expression ...... donic acid epoxygenase isoform
@en
Molecular cloning, expression ...... donic acid epoxygenase isoform
@nl
P921
P356
P1476
Molecular cloning, expression ...... donic acid epoxygenase isoform
@en
P2093
Capdevila JH
P356
10.1006/ABBI.1995.1438
P407
P577
1995-09-01T00:00:00Z